Fol. Biol. 2010, 56, 206-210
https://doi.org/10.14712/fb2010056050206
Th1/Th2 Cytokine Gene Polymorphisms in Patients With Uterine Fibroid
References
1. 1994) Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum. Genet. 94, 665-670.
, T. I., Heimdal, K. R., Skrede, M., Tveit, K., Berg, K., Borresen, A. L. (
2. 2000) Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil. Steril. 73, 1006-1011.
< , A., Sozen, I. (https://doi.org/10.1016/S0015-0282(00)00418-0>
3. 2005) The role of tumor stroma in the interaction between tumor and immune system. Curr. Opin. Immunol. 17, 180-186.
< , T. (https://doi.org/10.1016/j.coi.2005.01.008>
4. 1997) Polymorphism in the tumor necrosis factor-α promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer 80, 1489-1496.
< , L., Ahmed, S. B., Baccouche, S., Remadi, S. (https://doi.org/10.1002/(SICI)1097-0142(19971015)80:8<1489::AID-CNCR17>3.0.CO;2-1>
5. 2007) Uterine fibroid tumors: diagnosis and treatment. Am. Fam. Physician 75, 1503-1508.
, P., Brunsell, S. (
6. 2008) Hysterectomy for benign disease. Obstet. Gynecol. 111, 753-767.
< , T., Walters, M. D. (https://doi.org/10.1097/AOG.0b013e318165f18c>
7. 1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102, 1369-1376.
< , D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J. S., Humphries, S., Woo, P. (https://doi.org/10.1172/JCI2629>
8. 2003) Etiology and pathogenesis of uterine leiomyomas: a review. Environ. Health Perspect. 111, 1037-1054.
< , G. P., Andersen, J., Dixon, D. (https://doi.org/10.1289/ehp.5787>
9. 1991) Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254, 713-716.
< , P. T., Lazenby, A. J., Levitsky, H. I., Jaffee, L. M., Karasuyama, H., Baker, M., Pardoll, D. M. (https://doi.org/10.1126/science.1948050>
10. 1993) Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon γ. Proc. Natl. Acad. Sci. USA 90, 2774-2778.
< , H., Dorsch, M., Kunzendorf, U., Qin, Z., Diamantstein, T., Blankenstein, T. (https://doi.org/10.1073/pnas.90.7.2774>
11. 1994) Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy. Nat. Immun. 13, 85-92.
, H., Dorsch, M., Richter, G., Kunzendorf, U., KrugerKrasagakes, S., Blankenstein, T., Qin, Z., Diamantstein, T. (
12. 2004) Tumor necrosis factor-α-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas. Fertil. Steril. 82 Suppl 3, 1177-1181.
< , Y. Y., Chang, C. C., Tsai, F. J., Lin, C. C., Yeh, L. S., Tsai, C. H. (https://doi.org/10.1016/j.fertnstert.2004.03.035>
13. 2007) Interleukin (IL)-12 receptor β1 codon 378 G homozygote and allele, but not IL-1 (β-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3'-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma. Fertil. Steril. 87, 886-895.
< , Y. Y., Chang, C. C., Tsai, C. H., Lin, C. C., Tsai, F. J. (https://doi.org/10.1016/j.fertnstert.2006.07.1541>
14. 2003) Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp. Eur. J. Obstet. Gynecol. Reprod. Biol. 111, 197-203.
< , N., Ung, L., Otani, T., Wilkinson, D., Lopata, A. (https://doi.org/10.1016/S0301-2115(03)00244-6>
15. 2007) Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study. Exp. Oncol. 29, 295-298.
, K. V., Domenyuk, V. P., Bubnov, V. V., Zaporozhan, V. N. (
16. 2003) Effects of progesterone on growth factor expression in human uterine leiomyoma. Steroids 68, 817-824.
< , T., Matsuo, H., Shimomura, Y., Kurachi, O., Gao, Z., Nakago, S., Yamada, T., Chen, W., Wang, J. (https://doi.org/10.1016/j.steroids.2003.08.017>
17. 2007) Etiology, symptomatology, and diagnosis of uterine myomas. Fertil. Steril. 87, 725-736.
< , W. H. (https://doi.org/10.1016/j.fertnstert.2007.01.093>
18. 2009) Uterine leiomyoma is associated with a polymorphism in the interleukin 1-β gene. Am. J. Reprod. Immunol. 62, 112-117.
< , D., Thewes, R., Sator, M., Denschlag, D., Keck, C., Tempfer, C. (https://doi.org/10.1111/j.1600-0897.2009.00718.x>
19. 1997) Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am. J. Respir. Crit. Care Med. 156, S152-S155.
< , L. J., Borish, L. (https://doi.org/10.1164/ajrccm.156.4.12tac-14>
20. 1998) Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J. Clin. Endocrinol. Metab. 83, 2192-2198.
, Y., Matsuo, H., Samoto, T., Maruo, T. (
21. 2007) Cytokine gene polymorphisms in the Dutch population. Int. J. Immunogenet. 34, 87-90.
< , N., Kolesár, L., Striz, I., Lardy, N. M., Slavcev, A. (https://doi.org/10.1111/j.1744-313X.2007.00663.x>
22. 2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev. 20, 43-59.
< , A. J., Humphries, S. E. (https://doi.org/10.1016/j.cytogfr.2008.11.006>
23. 2006) The genetics of uterine leiomyomata: what clinicians need to know. Obstet. Gynecol. 107, 917-921.
< , E. A., Morton, C. C. (https://doi.org/10.1097/01.AOG.0000206161.84965.0b>
24. 2008) Expression of mRNA for chemokines and chemokine receptors in tissues of the myometrium and uterine leiomyoma. Bull. Exp. Biol. Med. 145, 84-89.
< , K. A., Kulagina, N. V., Chukhlovin, A. B., Morozova, E. B., Totolian, A. A. (https://doi.org/10.1007/s10517-008-0038-1>
25. 1989) Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57, 503-512.
< , R. I., Pattengale, P. K., Leder, P. (https://doi.org/10.1016/0092-8674(89)90925-2>
26. 1997) Cytokine gene polymorphism and heart transplant rejection. Transplantation 64, 776-779.
< , D., Grant, S. C., Yonan, N., Sheldon, S., Dyer, P. A., Sinnott, P. J., Hutchinson, I. V. (https://doi.org/10.1097/00007890-199709150-00021>
27. 1997) Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94, 3195-3199.
< , A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., Duff, G. W. (https://doi.org/10.1073/pnas.94.7.3195>